VEGFA and gastric cancer: TP53 mutations are found in 50% of intestinal-type gastric cancer, mainly characterized by chromosomal instability (CIN, 49%), aneuploidy and focal amplification, and they were observed to affect receptor tyrosine kinases, VEGFA and cell cycle mediators.